THARISA NON LIST. DL-001 Total Liabilities
THARISA NON LIST. DL-001 total liabilities. Based on the latest financial reports, THARISA NON LIST. DL-001 (7YZ) has total liabilities worth €390.23 Million EUR (≈ $456.22 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See THARISA NON LIST. DL-001 (7YZ) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of THARISA NON LIST. DL-001 (2022–2025)
Total liabilities of THARISA NON LIST. DL-001 from 2022 to 2025. This chart illustrates how THARISA NON LIST. DL-001's total liabilities have evolved over time, based on quarterly financial data. Check 7YZ asset resilience ratio to evaluate the company's liquid asset resilience ratio.
THARISA NON LIST. DL-001 Competitors by Total Liabilities
The table below lists competitors of THARISA NON LIST. DL-001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$2.73 Billion |
|
Grupo Rotoplas SAB de CV
MX:AGUA
|
Mexico | MX$7.83 Billion |
|
New Power Plasma Co.Ltd
KQ:144960
|
Korea | ₩567.46 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$3.12 Billion |
|
Pro Real Estate Investment Trust
TO:PRV-UN
|
Canada | CA$578.57 Million |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
China | CN¥221.06 Million |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
|
China | CN¥427.31 Million |
|
Empresa Distribuidora y Comercializadora Norte S.A.
BA:EDN
|
Argentina | AR$3.61 Trillion |
Liability Composition Analysis (2022–2025)
This chart breaks down THARISA NON LIST. DL-001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see THARISA NON LIST. DL-001 asset portfolio.
Liquidity & Leverage Metrics
THARISA NON LIST. DL-001 Total Liabilities Ratios Explained
THARISA NON LIST. DL-001 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how THARISA NON LIST. DL-001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for THARISA NON LIST. DL-001 (2022–2025)
The table below shows the annual total liabilities of THARISA NON LIST. DL-001 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | €390.23 Million ≈ $456.22 Million |
-8.87% |
| 2024-09-30 | €428.22 Million ≈ $500.63 Million |
+3.72% |
| 2023-09-30 | €412.87 Million ≈ $482.69 Million |
+24.01% |
| 2022-09-30 | €332.94 Million ≈ $389.24 Million |
-- |
About THARISA NON LIST. DL-001
Tharisa plc, an investment holding company, engages in the mining, processing, sale, and logistics of platinum group metals (PGMs) and chrome concentrates in South Africa, China, Singapore, Hong Kong, the United Arab Emirates, and internationally. It operates through four segments: PGM, Chrome, Agency and Trading, and Manufacturing. The company sells PGM concentrates, including platinum, palladiu… Read more